Neuroendocrine Tumor-II as a Primary in the Central Nervous System

Malignancies known as neuroendocrine neoplasms (NENs) have sporadic instances of developing central nervous system. It was discovered that a 36-year- old lady had a primary Neuroendocrine tumor of the brain who presented with headache, vomiting, and hearing difficulty from the left ear and was diagnosed with a left cerebellopontine angle solid mass. After subtotal excision, histology revealed a Neuroendocrine tumor-II. Adjuvant radiation was administered following a thorough search for an extracranial main tumour, which included the use of Ga-68 DOTANOC- PET-CT. This led to the identification of a primary central nervous system Neuroendocrine tumor. The patient was free of metastatic or recurrent disease at 9 months of follow-up.

Authors

Publication Details

Journal
International Journal of Innovative Science and Research Technology (IJISRT)
Published
2024-08-30
DOI
https://doi.org/10.38124/ijisrt/ijisrt24aug881
Citations
1
Primary Topic
Neuroendocrine Tumor Research Advances
Type
article
Field-Weighted Citation Impact
0.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Neuroendocrine Tumor-II as a Primary in the Central Nervous System

Shrutikant Bhatia, Vandana Thakur, Hardik Sharma, Kushal Rawal
1 citations
International Journal of Innovative Science and Research Technology (IJISRT)
Neuroendocrine Tumor Research Advances
0.39
article

Neuroendocrine Tumor-II as a Primary in the Central Nervous System

Shrutikant Bhatia, Vandana Thakur, Hardik Sharma, Kushal Rawal
article en
1 citations

Abstract

Malignancies known as neuroendocrine neoplasms (NENs) have sporadic instances of developing central nervous system. It was discovered that a 36-year- old lady had a primary Neuroendocrine tumor of the brain who presented with headache, vomiting, and hearing difficulty from the left ear and was diagnosed with a left cerebellopontine angle solid mass. After subtotal excision, histology revealed a Neuroendocrine tumor-II. Adjuvant radiation was administered following a thorough search for an extracranial main tumour, which included the use of Ga-68 DOTANOC- PET-CT. This led to the identification of a primary central nervous system Neuroendocrine tumor. The patient was free of metastatic or recurrent disease at 9 months of follow-up.

International Journal of Innovative Science and Research Technology (IJISRT)
Openalex Percentile: Top 35%
Neuroendocrine Tumor Research Advances
0.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.